The success of pharmaceutical companies in developing drugs for treating and curing medical conditions is largely dependent on the quality and completeness of data they gather from clinical trials and ...

Most companies today are building their AI strategy around structured data because unstructured data is operationally hard.

Inconsistent wording, inaccessible files and outdated references don’t just annoy regulators — they confuse customers and train LLMs on the wrong story. The strict regulatory landscape and rise of ...

A study conducted at the State University of Campinas (UNICAMP) in the state of São Paulo, Brazil, has proven the efficiency ...

To understand complex brain processes, there is a clear need to shift from traditional single-cell studies of trial-averaged responses to single-trial analyses of multiple neurons. In this respect, ...

Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at ...

ATLANTA, November 11, 2025--(BUSINESS WIRE)--Volato Group, Inc. (NYSE American: SOAR) (the "Company") announced that it will showcase Parslee—its enterprise document-intelligence platform—at Microsoft ...

Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at medical records. But this information is often incomplete.

The key is to balance offense and defense. by Leandro DalleMule and Thomas H. Davenport More than ever, the ability to manage torrents of data is critical to a company’s success. But even with the ...

You may think of Google Drive mostly as a cloud storage service, but it’s also the foundation for the company’s online productivity apps including Google Docs, Google Sheets, and Google Slides, where ...